surpass 4 tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial 🫀 EASD 2025: Tirzepatide (SURPASS-CVOT)

Because glutathione is able to locate and convert free radicals into molecules the body can process, glutathione protects us from the damaging effects of free radical damage

IV therapy is an effective way to ensure your body is saturated with vital nutrients that it can readily use

The clinical study group, investigators and all other personnel and participants, except for staff conducting the treatment allocation, were blinded to the randomisation throughout the trial

The highest six shipments had reported volumes that ranged between 23kg and 50kgall so high they might appear as reporting mistakes, but FDA data suggest that each first large shipment was initially detained for each company at the border and subsequently released

In the liver, AMPK activation remains instrumental for regulating glucose uptake while blocking cholesterol and triglyceride synthesis [31]

These mechanisms are plausible but not proven to be causal for new-onset vaginal pathology